Meghan Verena Joyce - 04 Dec 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
04 Dec 2022
Net transactions value
$0
Form type
4
Filing time
06 Dec 2022, 16:24:04 UTC
Previous filing
08 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +66 +6.6% $0.000000 1,061 04 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -66 -3% $0.000000 2,124 04 Dec 2022 COMMON STOCK 66 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.